Cargando…
Danicamtiv Increases Myosin Recruitment and Alters Cross-Bridge Cycling in Cardiac Muscle
BACKGROUND: Modulating myosin function is a novel therapeutic approach in patients with cardiomyopathy. Danicamtiv is a novel myosin activator with promising preclinical data that is currently in clinical trials. While it is known that danicamtiv increases force and cardiomyocyte contractility witho...
Autores principales: | Kooiker, Kristina B., Mohran, Saffie, Turner, Kyrah L., Ma, Weikang, Martinson, Amy, Flint, Galina, Qi, Lin, Gao, Chengqian, Zheng, Yahan, McMillen, Timothy S., Mandrycky, Christian, Mahoney-Schaefer, Max, Freeman, Jeremy C., Costales Arenas, Elijah Gabriela, Tu, An-Yu, Irving, Thomas C., Geeves, Michael A., Tanner, Bertrand C.W., Regnier, Michael, Davis, Jennifer, Moussavi-Harami, Farid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434831/ https://www.ncbi.nlm.nih.gov/pubmed/37470183 http://dx.doi.org/10.1161/CIRCRESAHA.123.322629 |
Ejemplares similares
-
Structural OFF/ON transitions of myosin in relaxed porcine myocardium predict calcium-activated force
por: Ma, Weikang, et al.
Publicado: (2023) -
Modulating the tension-time integral of the cardiac twitch prevents dilated cardiomyopathy in murine hearts
por: Powers, Joseph D., et al.
Publicado: (2020) -
The Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications
por: Ráduly, Arnold Péter, et al.
Publicado: (2022) -
Danicamtiv Enhances Systolic Function and Frank‐Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium
por: Shen, Shi, et al.
Publicado: (2021) -
Machine learning meets Monte Carlo methods for models of muscle’s molecular machinery to classify mutations
por: Asencio, Anthony, et al.
Publicado: (2023)